Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2017

Every FDA drug recall initiated in 2017, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,141 recalls, newest first.

Class II · Moderate risk

Acarbose Tablets

Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.

Terminated Labeling / mix-up Teva Pharmaceuticals USA NDC 16252-523-01 D-1178-2017
Class III · Low risk

Phentermine

Failed Impurities/Degradation Specification; out-of-specification results for individual unknown impurities at the 30 month Room Temperature Retained Sample stability test

Terminated Temperature excursion Aidarex Pharmaceuticals LLC D-1162-2017
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0160-2018
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0159-2018
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0158-2018
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0157-2018
Class II · Moderate risk

Urin D/S Tablets Methenamine 81.6 mg

Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.

Terminated Wrong potency / content Llorens Pharmaceutical Corp. D-0081-2018
Class III · Low risk

ENALAPRIL MALEATE Tablets

Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.

Terminated Impurity / degradation Aidarex Pharmaceuticals LLC NDC 33261-0693-90 D-0053-2018

Recalls by year